Filter posts

John Lechleiter Forbes Op-Ed: Debunking the Five Big Myths About 'Big Pharma'

This week, Eli Lilly and Company President, Chairman and CEO John Lechleiter refutes five big …

More Than 90 Patient Organizations Urge Congress to Protect Patients and Innovation

Today, the Epilepsy Foundation and a diverse group of more than 90 advocacy organizations submitted …

Solazyme CEO Jonathan S. Wolfson to Receive the 2015 BIO George Washington Carver Award

In recent news, BIO has named Solazyme CEO and co-founder Jonathan S. Wolfson as the …

Morning Consult: Right-Sized Regulations, Innovation and Investor Protection

Today, an op-ed from BIO President and CEO Jim Greenwood appeared in Morning Consult stressing …

The White House Releases its Strategy for Restoring Pollinator Habitats

Today, The White House released its┬áNational Strategy to Promote the Health of Honey Bees and …

BIO Innovation Zone Company Snapshots: ONL Therapeutics and Lipella Pharmaceuticals

Next month in Philadelphia at the┬áBIO International Convention, BIO will be partnering with the National …